News • 01/2015
Gilead, Novartis, Roche: looking ahead to 2015 with Acte Sept!
![[+pagetitle+]](/assets/components/phpthumbof/cache/image6.a6a2b4130392c03d599a4d6c2d5efcef.jpg)
January was a busy month for the Acte Sept teams, tasked with supporting three major healthcare players in France with their internal communication appointments. Crucial appointments for succeeding in 2015.
Specific stakes...
- For Gilead: gaining the customer's preference beyond the revolution in medicine,
- For Novartis: giving meaning to a change in organisation that matches patients' needs,
- For Roche: deploying its new business model to foster access to innovation in France.
...with one common lever: placing spoken communication at the heart of the system to ensure team involvement and to share the roadmap enthusiastically and emphatically.